G49108TO

Summary
GlyTouCan ID
G49108TO
IUPAC Condensed
GlcNAc(b1-
3D Structures
GLYCAM
DGlcpNAcb1-OH
GlycoShape
G49108TO
Displaying 1 entry
Archetype α β
G14843DJ
G68544GH
G49108TO
Organisms
Taxonomic Hierarchy
GlycoGene Database (GGDB)
Displaying entries 1 - 5 of 10 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT5 (not applicable)
G49108TO
[beta]-S-pNP
G00055MO
[beta]-S-pNP
B4GALT1 UDP-Gal
G49108TO
R
G00055MO
R
B4GALT2 UDP-Gal
G49108TO
Benzyl-[beta]
G00055MO
Benzyl-[beta]
B3GALT2 UDP-Gal
G49108TO
Lemieux
G00056MO
Lemieux
B3GALT5 UDP-Gal
G49108TO
R
G00056MO
R
Displaying entries 1 - 5 of 25 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Product Reducing terminal(Product) Reference
B4GALT5 (not applicable)
G49108TO
[beta]-S-pNP
G00055MO
[beta]-S-pNP
B4GALT4 UDP-Gal
G49108TO
[beta]-1-thio-p-Nitrophenyl
G00055MO
[beta]-1-thio-p-Nitrophenyl
B4GALT3 UDP-Gal
G49108TO
4-Me-lumbelyl-[beta]
G00055MO
4-Me-lumbelyl-[beta]
B4GALT4 UDP-Gal
G49108TO
[beta]-1-4-methyl-umbelliferyl
G00055MO
[beta]-1-4-methyl-umbelliferyl
B4GALT1 UDP-Gal
G49108TO
G00055MO
Displaying entries 16 - 20 of 24 in total
Gene Symbol Donor Acceptor Reducing terminal(Acceptor) Reference
B3GALNT2 UDP-GalNAc
G49108TO
[alpha]-Bz
B3GLCT UDP-Glc
G49108TO
[beta]-benzyl
B3GNT2 UDP-GlcNAc
G49108TO
[beta]1-OBn
MGAT5 UDP-GlcNAc
G49108TO
B3GNT8 UDP-GlcNAc
G49108TO
[alpha]-Bz
KEGG BRITE Database
KEGG ID
Enzyme
GlycoEpitope
Epitope ID
EP0004
Pathway
Displaying entries 31 - 40 of 127 in total
Pathway Name Organism
E.coli O137 Escherichia coli
E.coli O138 Escherichia coli
E.coli O141 Escherichia coli
E.coli O142 Escherichia coli
E.coli O143 Escherichia coli
E.coli O145 Escherichia coli
E.coli O149 Escherichia coli
E.coli O15 Escherichia coli
E.coli O150 Escherichia coli
E.coli O151 Escherichia coli
Sequence Descriptors
GlycoCT
RES
1b:b-dglc-HEX-1:5
2s:n-acetyl
LIN
1:1d(2+1)2n
WURCS
WURCS=2.0/1,1,0/[a2122h-1b_1-5_2*NCC/3=O]/1/
Literature
Displaying entries 951 - 960 of 10696 in total
PubMed ID Title First Author Publication Date Source
35662412 Potent cross-reactive antibodies following Omicron breakthrough in vaccinees Nutalai R 2022 Jun 09
  • PubChem
35436443 35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope Wang X 2022 Jun 08
  • PubChem
35672408 Molecular basis of mEAK7-mediated human V-ATPase regulation Wang R 2022 Jun 07
  • PubChem
35420233 Broad‐Spectrum Antidote Discovery by Untangling the Reactivation Mechanism of Nerve‐Agent‐Inhibited Acetylcholinesterase Lindgren C 2022 Jun 07
  • PubChem
35672388 Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages Wang L 2022 Jun 07
  • PubChem
35658032 Patched 1 regulates Smoothened by controlling sterol binding to its extracellular cysteine-rich domain Kinnebrew M 2022 Jun 03
  • PubChem
35148377 Structural basis of von Willebrand factor multimerization and tubular storage Zeng J 2022 Jun 02
  • PubChem
35655099 Structure, dynamics and assembly of the ankyrin complex on human red blood cell membrane Xia X 2022 Jun 02
  • PubChem
35654847 A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike protein Khatri B 2022 Jun 02
  • PubChem
35447081 Structural diversity of the SARS-CoV-2 Omicron spike Gobeil SM- 2022 Jun 02
  • PubChem

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.4.0

Last updated: December 8, 2025